Tuesday, December 11, 2007 8:17:04 AM
xrymd,
I largely agree with you.
This will be a safer buy after funding is certain.
But the decline has priced in some of the risk. And rather than the decline continuing the stock has been stable and started rising. At the same time we see filings of a large owner that is adding here. They are adding DESPITE the obvious funding needs. The clear inference is that they are not put off by the funding issue.
Seems to me that it is time to take a partial position in RPRX with the knowledge that if the stock sells off further on funding that it is time to complete the position.
zip
Some personal comments. Thomas has had rational comments to make but his attacks on Nerf have been distracting. And now Nerf has blown up at Thomas detracting from substance. Telling those who are not perma-bulls to stop posting is not helpful. JMHO
PS - Nerf is a great guy who is more emotional in his expressions than some others. Too bad he can't bottle some of that and give it to me.
I largely agree with you.
This will be a safer buy after funding is certain.
But the decline has priced in some of the risk. And rather than the decline continuing the stock has been stable and started rising. At the same time we see filings of a large owner that is adding here. They are adding DESPITE the obvious funding needs. The clear inference is that they are not put off by the funding issue.
Seems to me that it is time to take a partial position in RPRX with the knowledge that if the stock sells off further on funding that it is time to complete the position.
zip
Some personal comments. Thomas has had rational comments to make but his attacks on Nerf have been distracting. And now Nerf has blown up at Thomas detracting from substance. Telling those who are not perma-bulls to stop posting is not helpful. JMHO
PS - Nerf is a great guy who is more emotional in his expressions than some others. Too bad he can't bottle some of that and give it to me.
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)
Recent RPRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2026 08:48:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 08:01:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 09:49:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 01:20:12 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2026 08:23:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:38:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/14/2026 09:22:49 PM
- Form 13F-NT - Quarterly report filed by institutional managers, Notice • Edgar (US Regulatory) • 05/14/2026 06:29:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:14:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:12:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 09:10:50 PM
- Royalty Pharma to present at upcoming investor conferences • GlobeNewswire Inc. • 05/07/2026 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 01:04:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:31:54 AM
- Royalty Pharma reports first quarter 2026 results • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/30/2026 09:54:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/28/2026 09:00:16 PM
- Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation • GlobeNewswire Inc. • 04/21/2026 05:00:00 PM
- Royalty Pharma Declares Second Quarter 2026 Dividend • GlobeNewswire Inc. • 04/17/2026 12:30:00 PM
- Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/15/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 01:53:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2026 08:11:03 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 08:10:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:58:57 PM
